- Home
- PLX vs SGC Comparison
PLX vs SGC Comparison
Compare PLX & SGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLX | SGC |
|---|---|---|
| Founded | 1993 | 1920 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 230.0M | 168.2M |
| IPO Year | 1996 | 1994 |
Fundamental Metrics
Financial Performance| Metric | PLX | SGC |
|---|---|---|
| Price | $2.84 | $10.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $12.00 | ★ $17.33 |
| AVG Volume (30 Days) | ★ 1.7M | 32.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.56% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.46 |
| Revenue | $53,399,000.00 | ★ $566,184,000.00 |
| Revenue This Year | $9.67 | $0.73 |
| Revenue Next Year | $23.86 | $3.38 |
| P/E Ratio | ★ N/A | $43.70 |
| Revenue Growth | N/A | ★ 0.09 |
| 52 Week Low | $1.34 | $8.30 |
| 52 Week High | $3.19 | $14.46 |
Technical Indicators
Market Signals| Indicator | PLX | SGC |
|---|---|---|
| Relative Strength Index (RSI) | 53.68 | 50.82 |
| Support Level | $1.39 | $9.76 |
| Resistance Level | $3.03 | $10.48 |
| Average True Range (ATR) | 0.15 | 0.39 |
| MACD | -0.05 | -0.03 |
| Stochastic Oscillator | 15.66 | 40.40 |
Price Performance
Historical ComparisonAbout PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About SGC Superior Group of Companies Inc.
Superior Group Of Companies Inc designs apparel products. The company's operating segment includes Branded Products; Healthcare Apparel and Contact Centers. It generates maximum revenue from the Branded Products segment. The Branded Products segment produce and sell customized merchandising solutions, promotional products and branded uniform programs to customers.